In an effort to help healthcare organizations achieve more from their analytics – and better position them to take on new artificial intelligence and machine learning initiatives – InterSystems has ...
Intercept Pharmaceuticals Inc ICPT announced initial results from a planned interim analysis of its ongoing Phase 2 study 747-213, an active comparator trial demonstrating the therapeutic potential of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback